Primary mediastinal B-cell lymphoma: Treatment and therapeutic targets

Leukemia and Lymphoma

Volumn 49, Issue 6, 2008, Pages 1050-1061

  Rodríguez, José ^a   Gutiérrez, Antonio ^b   Piris, Miguel ^c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Primary mediastinal B cell lymphoma; Targets; Treatment

Indexed keywords

3' FLUOROTHYMIDINE; ASPARAGINASE; BETA 2 MICROGLOBULIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; JANUS KINASE 2; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; PROCARBAZINE; RITUXIMAB; STAT6 PROTEIN; TRANSCRIPTION FACTOR REL; VINCRISTINE; VINCRISTINE SULFATE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DISEASE MARKER; DRUG MEGADOSE; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; MEDIASTINUM CANCER; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIMARY MEDIASTINUM B CELL LYMPHOMA; PRIORITY JOURNAL; REVIEW; TUMOR LOCALIZATION; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION PROFILING; HUMANS; IMMUNOTHERAPY; LYMPHOMA, B-CELL; MEDIASTINAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 46749110103     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190801958994     Document Type: Review

References (78)

1. Haioun, C., Gaulard, P., Roudot-Thoraval, F., Divine, M., Jouault, H. Lebourgeois, J. P. et al. (1989) Mediastinal diffuse large-cell lymphoma with sclerosis: A condition with a poor prognosis. Am J Clin Oncol, 12, pp. 425-429.
2. Lazzarino, M., Orlandi, E., Paulli, M., Boveri, E., Morra, E. Brusamolino, E. et al. (1993) Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumour with distinctive clinical and pathologic features. J Clin Oncol, 11, pp. 2306-2313.
3. Todeschini, G., Ambrosetti, A., Meneghini, V., Pizzolo, G., Menestrina, F. Chilosi, M. et al. (1990) Mediastinal large-B-cell lymphoma with sclerosis: A clinical study of 21 patients. J Clin Oncol, 8, pp. 804-808.
4. Lavabre-Bertrand, T., Donadio, D., Fegueux, N., Jessueld, D., Taib, J. Charlier, D. et al. (1992) A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer, 69, pp. 2561-2566.
5. Savage, K. J., Monti, S., Kutok, J. L., Cattoretti, G., Neuberg, D. De Leval, L. et al. (2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood, 102, pp. 3871-3879.
6. Rosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P. Gascoyne, R. D. et al. (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med, 198, pp. 851-862.
7. Rodriguez, J., Pugh, W. C., Romaguera, J. E. and Cabanillas, F. (1994) Primary mediastinal large cell lymphoma. Hematol Oncol, 12, pp. 175-184.
8. Banks, P. M. and Warnke, R. A. (2001) Mediastinal (thymic) large B-cell lymphoma. World Health Organization Classification of Tumours. Pathology and genetics of Tumours of Hematopoietic and Lymphoid Tissues, IARC Press, Lyon
9. Miller, J. B., Variakojis, D., Bitran, J. D., Sweet, D. L., Kinzie, J. J. Golomb, H. M. et al. (1981) Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction. Cancer, 47, pp. 748-756.
10. Trump, D. L. and Mann, R. B. (1982) Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer, 50, pp. 277-282.
11. Levitt, L. J., Aisenberg, A. C., Harris, N. L., Linggood, R. M. and Poppema, S. (1982) Primary non-Hodgkin's lymphoma of the mediastinum. Cancer, 50, pp. 2486-2492.
12. Rodriguez, J., Pugh, W. C., Romaguera, J. E., Luthra, R., Hagemeister, F. B. McLaughlin, P. et al. (1994) Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoural mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase. Ann Oncol, 5, pp. 847-849.
13. Scarpa, A., Borgato, L., Chilosi, M., Capelli, P., Menestrina, F. Bonetti, F. et al. (1991) Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood, 78, pp. 780-788.
14. Joos, S., Otano-Joos, M. I., Ziegler, S., Bruderlein, S., du Manoir, S Bentz, M. et al. (1996) Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood, 87, pp. 1571-1578.
15. Scarpa, A., Taruscio, D., Scardoni, M., Iosi, F., Paradisi, S. Ennas, M. G. et al. (1999) Nonrandom chromosomal imbalances in primary mediastinal B-cell lymphoma detected by arbitrarily primed PCR fingerprinting. Genes Chromosomes Cancer, 26, pp. 203-209.
16. Melzner, I., Bucur, A. J., Bruderlein, S., Dorsch, K., Hasel, C. Barth, T. F. et al. (2005) Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood, 105, pp. 2535-2542.
17. Mestre, C., Rubio-Moscardo, F., Rosenwald, A., Climent, J., Dyer, M. J. Staudt, L. et al. (2005) Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays. Leukemia, 19, pp. 1082-1084.
18. Traverse-Glehen, A., Pittaluga, S., Gaulard, P., Sorbara, L., Alonso, M. A. Raffeld, M. et al. (2005) Mediastinal gray zone lymphoma: The missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol, 29, pp. 1411-1421.
19. Garcia, J. F., Mollejo, M., Fraga, M., Forteza, J., Muniesa, J. A. Perez-Guillermo, M. et al. (2005) Large B-cell lymphoma with Hodgkin's features. Histopathology, 47, pp. 101-110.
20. Copie-Bergman, C., Gaulard, P., Maouche-Chretien, L., Briere, J., Haioun, C. Alonso, M. A. et al. (1999) The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood, 94, pp. 3567-3575.
21. Hsi, E. D., Sup, S. J., Alemany, C., Tso, E., Skacel, M. Elson, P. et al. (2006) MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol, 125, pp. 776-782.
22. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T. Nishimura, H. et al. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med, 192, pp. 1027-1034.
23. Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M. Chernova, I. et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol, 2, pp. 261-268.
24. Kluiver, J., Poppema, S., de Jong, D., Blokzijl, T., Harms, G. Jacobs, S. et al. (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol, 207, pp. 243-249.
25. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S. Rosenwald, A. et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, pp. 503-511.
26. Pileri, S. A., Gaidano, G., Zinzani, P. L., Falini, B., Gaulard, P. Zucca, E. et al. (2003) Primary mediastinal B-cell lymphoma: High frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB 1, and PU.1 in the absence of immunoglobulins. Am J Pathol, 162, pp. 243-253.
27. Guiter, C., Dusanter-Fourt, I., Copie-Bergman, C., Boulland, M. L., Le Gouvello, S Gaulard, P. et al. (2004) Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood, 104, pp. 543-549.
28. Niiro, H. and Clark, E. A. (2002) Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol, 2, pp. 945-956.
29. Banham, A. H., Beasley, N., Campo, E., Fernandez, P. L., Fidler, C. Gatter, K. et al. (2001) The FOXP1 winged helix transcription factor is a novel candidate tumour suppressor gene on chromosome 3p. Cancer Res, 61, pp. 8820-8829.
30. Skinnider, B. F., Elia, A. J., Gascoyne, R. D., Trumper, L. H., von Bonin, F. Kapp, U. et al. (2001) Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood, 97, pp. 250-255.
31. Ohshima, K., Akaiwa, M., Umeshita, R., Suzumiya, J., Izuhara, K. and Kikuchi, M. (2001) Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis. Histopathology, 38, pp. 368-375.
32. Copie-Bergman, C., Boulland, M. L., Dehoulle, C., Moller, P., Farcet, J. P. Dyer, M. J. et al. (2003) Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. Blood, 101, pp. 2756-2761.
33. Peh, S. C., Kim, L. H. and Poppema, S. (2001) TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol, 25, pp. 925-929.
34. Schwab, U., Stein, H., Gerdes, J., Lemke, H., Kirchner, H. Schaadt, M. et al. (1982) Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature, 299, pp. 65-67.
35. Feuerhake, F., Kutok, J. L., Monti, S., Chen, W., LaCasce, A. S. Cattoretti, G. et al. (2005) NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood, 106, pp. 1392-1399.
36. de Leval, L., Ferry, J. A., Falini, B., Shipp, M. and Harris, N. L. (2001) Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: Evidence for derivation from germinal center B cells?. Am J Surg Pathol, 25, pp. 1277-1282.
37. Weniger, M. A., Pulford, K., Gesk, S., Ehrlich, S., Banham, A. H. Lyne, L. et al. (2006) Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia, 20, pp. 1880-1882.
38. Hsu, F. J. and Levy, R. (1995) Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood, 86, pp. 3072-3082.
39. Kuppers, R., Klein, U., Hansmann, M. L. and Rajewsky, K. (1999) Cellular origin of human B-cell lymphomas. N Engl J Med, 341, pp. 1520-1529.
40. Kuppers, R., Rajewsky, K. and Hansmann, M. L. (1997) Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol, 27, pp. 1398-1405.
41. Malpeli, G., Barbi, S., Moore, P. S., Scardoni, M., Chilosi, M. Scarpa, A. et al. (2004) Primary mediastinal B-cell lymphoma: Hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas. Haematologica, 89, pp. 1091-1099.
42. Staudt, L. M. and Dave, S. (2005) The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol, 87, pp. 163-208.
43. Takahashi, H., Feuerhake, F., Monti, S., Kutok, J. L., Aster, J. C. and Shipp, M. A. (2006) Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma. Blood, 107, pp. 844-845.
44. Calvo, K. R., Traverse-Glehen, A., Pittaluga, S. and Jaffe, E. S. (2004) Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: Implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol, 11, pp. 227-238.
45. Zamo, A., Malpeli, G., Scarpa, A., Doglioni, C., Chilosi, M. and Menestrina, F. (2005) Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas. Mod Pathol, 18, pp. 1448-1453.
46. Todeschini, G., Secchi, S., Morra, E., Vitolo, U., Orlandi, E. Pasini, F. et al. (2004) Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer, 90, pp. 372-376.
47. Zinzani, P. L., Martelli, M., Bertini, M., Gianni, A. M., Devizzi, L. Federico, M. et al. (2002) Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: A retrospective multinational study on 426 previously untreated patients. Haematologica, 87, pp. 1258-1264.
48. Savage, K. J., Al-Rajhi, N., Voss, N., Paltiel, C., Klasa, R. Gascoyne, R. D. et al. (2006) Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: The British Columbia experience. Ann Oncol, 17, pp. 123-130.
49. Hamlin, P. A., Portlock, C. S., Straus, D. J., Noy, A., Singer, A. Horwitz, S. M. et al. (2005) Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. Br J Haematol, 130, pp. 691-699.
50. Romaguera, J. E., Rodriguez Diaz-Pavon, J, Carias, L., Hagemeister, F. B., McLaughlin, P. Rodriguez, M. A. et al. (1998) Use of the international prognostic index and the tumour score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: A study of 37 previously untreated patients. Leuk Lymphoma, 28, pp. 295-306.
51. Rodriguez, J., Cabanillas, F., McLaughlin, P., Swan, F., Rodriguez, M. Hagemeister, F. et al. (1992) A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumour score'. Ann Oncol, 3, pp. 711-717.
52. Rodriguez, J., Conde, E., Gutierrez, A., Garcia-Ruiz, J. C., Lahuerta, J. J. Varela, M. R. et al. (2006) Front-line autologous stem cell transplantation (ASCT) in primary mediastinal large B-cell lymphoma: The GEL-TAMO experience. Blood, 108, p. 3056.
53. Lazzarino, M., Orlandi, E., Paulli, M., Strater, J., Klersy, C. Gianelli, U. et al. (1997) Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients. J Clin Oncol, 15, pp. 1646-1653.
54. Zinzani, P. L., Martelli, M., Bendandi, M., De Renzo, A., Zaccaria, A. Pavone, E. et al. (2001) Primary mediastinal large B-cell lymphoma with sclerosis: A clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica, 86, pp. 187-191.
55. Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M. Mize, E. M. et al. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med, 328, pp. 1002-1006.
56. Dunleavy, K., Pittaluga, S., Janik, J., Grant, N., Steinberg, S. Staudt, L. et al. (2005) Primary mediastinal large B-cell lymphoma (PMBL) outcome is significantly improved by the addition of rituximab to dose adjusted (DA)-EPOCH and overcomes the need for radiation. Blood, 106, p. 929.
57. Zinzani, P. L., Martelli, M., Magagnoli, M., Pescarmona, E., Scaramucci, L. Palombi, F. et al. (1999) Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood, 94, pp. 3289-3293.
58. Bieri, S., Roggero, E., Zucca, E., Bertoni, F., Pianca, S. Sanna, P. et al. (1999) Primary mediastinal large B-cell lymphoma (PMLCL): The need for prospective controlled clinical trials. Leuk Lymphoma, 35, pp. 139-146.
59. Kirn, D., Mauch, P., Shaffer, K., Pinkus, G., Shipp, M. A. Kaplan, W. D. et al. (1993) Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol, 11, pp. 1336-1343.
60. Cazals-Hatem, D., Lepage, E., Brice, P., Ferrant, A., d'Agay, M. F. Baumelou, E. et al. (1996) Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol, 20, pp. 877-888.
61. Adams, M. J., Lipsitz, S. R., Colan, S. D., Tarbell, N. J., Treves, S. T. Diller, L. et al. (2004) Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol, 22, pp. 3139-3148.
62. Sehn, L. H., Antin, J. H., Shulman, L. N., Mauch, P., Elias, A. Kadin, M. E. et al. (1998) Primary diffuse large B-cell lymphoma of the mediastinum: Outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood, 91, pp. 717-723.
63. Vose, J. M., Bierman, P. J., Anderson, J. R., Harrison, K. A., Dalrymple, G. V. Byar, K. et al. (1996) Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol, 14, pp. 2473-2479.
64. Popat, U., Przepiork, D., Champlin, R., Pugh, W., Amin, K. Mehra, R. et al. (1998) High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome. J Clin Oncol, 16, pp. 63-69.
65. Nademanee, A., Molina, A., O'Donnell, M. R., Dagis, A., Snyder, D. S. Parker, P. et al. (1997) Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: International index high and high-intermediate risk group. Blood, 90, pp. 3844-3852.
66. Rodriguez, J., Caballero, M. D., Gutierrez, A., Solano, C., Arranz, R. Lahuerta, J. J. et al. (2004) Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: The GEL/TAMO experience. Ann Oncol, 15, pp. 1504-1509.
67. Rodriguez, J. (2005) Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?. Nat Clin Pract Oncol, 2, pp. 74-75.
68. Moskowitz, C., Hamlin, P. A., Horwitz, S. M., Noy, A., O'Connor, O. A. Palomba, M. et al. (2006) Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL. Blood, 108, p. 532.
69. Dupuis, J., Gaulard, P., Hemery, F., Itti, E., Gisselbrecht, C. Rahmouni, A. et al. (2007) Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma. Haematologica, 92, pp. 778-783.
70. Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J. D. Belhadj, K. et al. (2005) [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: An early prognostic tool for predicting patient outcome. Blood, 106, pp. 1376-1381.
71. Sanchez-Beato, M., Sanchez-Aguilera, A. and Piris, M. A. (2003) Cell cycle deregulation in B-cell lymphomas. Blood, 101, pp. 1220-1235.
72. Jacobson, J. O., Aisenberg, A. C., Lamarre, L., Willett, C. G., Linggood, R. M. Miketic, L. M. et al. (1988) Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer, 62, pp. 1893-1898.
73. Bertini, M., Orsucci, L., Vitolo, U., Levis, A., Todeschini, G. Meneghini, V. et al. (1991) Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol, 2, pp. 733-737.
74. Falini, B., Venturi, S., Martelli, M., Santucci, A., Pileri, S. Pescarmona, E. et al. (1995) Mediastinal large B-cell lymphoma: Clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol, 89, pp. 780-789.
75. Zinzani, P. L., Bendandi, M., Frezza, G., Gherlinzoni, F., Merla, E. Salvucci, M. et al. (1996) Primary Mediastinal B-cell lymphoma with sclerosis: Clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma, 21, pp. 311-316.
76. Martelli, M. P., Martelli, M., Pescarmona, E., De Sanctis, V., Donato, V. Palombi, F. et al. (1998) MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol, 9, pp. 1027-1029.
77. Abou-Elella, A. A., Weisenburger, D. D., Vose, J. M., Kollath, J. P., Lynch, J. C. Bast, M. A. et al. (1999) Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol, 17, pp. 784-790.
78. Cairoli, R., Grillo, G., Tedeschi, A., Gargantini, L., Marenco, P. Tresoldi, E. et al. (2002) Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Bone Marrow Transplant, 29, pp. 473-477.